Tetravalent chimeric dengue vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tetravalent chimeric dengue vaccine, covering 2013-02-04 to 2018-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years [Phase 2]